Experimental Drug Switches Off Hunger in Patients with Genetic Obesity

Investigator-initiated Phase II study finds setmelanotide therapy in patients with leptin receptor gene mutations leads to dramatic reductions in appetite and body weight.

Source: Experimental Drug Switches Off Hunger in Patients with Genetic Obesity

About the Author

Stephanie Figon, MS, RDN, LD

Founder of NutriScape.NET. As a dietitian since 1992, Steph Figon has had experiences in consulting, 15 years in clinical, and has operated a private practice nutrition counseling office for since 2011. The RDNutriScape Instagram